Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
Houff
Sidney A
SA
Berger
Joseph
J
Major
Eugene O
EO
D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001773:Blood Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009103:Multiple Sclerosis / Q000097:blood / Q000188:drug therapy; D000069442:Natalizumab; D014158:Transcription, Genetic / Q000187:drug effects*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab